| Department Name | Source | Finacial Year | Amount Sanctioned | Purpose |
|---|
| World Health Organization | Overseas | 2016-2017 | 69684258 | Project Started on 21/06/2016. During FY 16-17 the support structure was setup. Amount sanctioned is for entire Study Duration.
Project Objectives:
1. To Compare rates of all-Cause mortality
2. To compare the average change in linear growth
in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo. |
| World Health Organization | Overseas | 2016-2017 | 30168000 | PROJECT OBJECTIVES:
1. To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea > 5 days)
2. To evaluate the safety of lower dose versus standard dose Zinc regarding vomiting and other adverse events, and
3. To Evaluate the acceptability of lower doses versus standard dose Zinc using an acceptability scale |
| World Health Organization | Overseas | 2015-2016 | 11656224 | The AMANHI STUDY, Using on-going newborn intervention trials to obtain additional data critical to maternal, fetal and newborn in a harmonized way. |
| Johns Hopkins Bloomberg School of Public Health | Overseas | 2014-2015 | 10924338 | Efficacy of High Zinc-Biofortified Wheat Consumption in Improvement of Micronutrient Status and Prevention of Morbidity among Pre-School Children (aged 4-6 Years) and Women of Child Bearing Age, A double Masked, Randomized, Controlled Trial. |
| World Health Organization | Overseas | 2017-2018 | 22459385 | Project Objectives:
1. To Compare rates of all-Cause mortality
2. To compare the average change in linear growth
in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo. |
| World Health Organization | Overseas | 2020-2021 | 14187047 | Project Objectives:
1. To Compare rates of all-Cause mortality
2. To compare the average change in linear growth
in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo.
|
| World Health Organization | Overseas | 2017-2018 | 21389573 | PROJECT OBJECTIVES:
1. To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea |
| World Health Organization | Overseas | 2018-2019 | 52828936 | 1. To Compare rates of all-Cause mortality
2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo. |
| World Health Organization | Overseas | 2018-2019 | 22146883 | PROJECT OBJECTIVES:
1. To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea |
| World Health Organization | Overseas | 2019-2020 | 55746372 | 1. To Compare rates of all-Cause mortality
2. To compare the average change in linear growth in the 90 days following an episode of high risk diarrhoea without dysentery among children 2 to 23 months of age living in low resource settings who are randomized to receive a 3-day course of azithromycin , a 3-day course of ciprofloxacin or placebo. |
| World Health Organization | Overseas | 2019-2020 | Not Specified | Leftover Funds Used from previous Year
PROJECT OBJECTIVES:
To evaluate the non-inferiority of lower Zinc doses (10 mg/day and 5 mg/day) versus standard Zinc Dose (20 mg/day) regarding diarrhoea (duration of symptoms, and risk of diarrhoea
|
